Patent Assignment
Reel/Frame 054245/0626
Assignment of Assignor's Interest
Recorded: 2020-11-02
Pages: 2
Assignee
XERIS PHARMACEUTICALS, INC.
180 N. LASALLE STREET, SUITE 1600, CHICAGO, ILLINOIS, 60601
Covered Property
(1)
Treatment of Post-Bariatric Hypoglycemia Using Mini-Dose Stable Glucagon
Application:
16/964,124 →
Publication:
US 2021/0030847
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 2, 2020
From: PATTI, MARY-ELIZABETH
To: JOSLIN DIABETES CENTER, INC.
Reel/Frame 054245/0816 →
Intellectual Property Security Agreement
May 4, 2021
From: XERIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 056135/0800 →
Security Interest
Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
Reassignment and Release of Security Interest
Mar 10, 2022
From: OXFORD FINANCE LLC
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 059358/0714 →